The American Journal of Managed Care

Adaptive SBRT May Reduce GU/GI Toxicity Risk in Prostate Cancer

A meta-analysis found that the use of magnetic resonance–guided daily adaptive stereotactic body radiotherapy (SBRT) correlated with fewer acute grade 2 or higher gastrointestinal (GI) or ...
technologynetworks

The Impact of MRI on Genitourinary and Gastrointestinal Toxicity after Radiation Therapy

MRI has several advantages relative to other imaging modalities in evaluating, diagnosing, and planning treatment for prostate cancer. However, it is rarely ordered for localized disease. While the ...
Nature

Comparison of late gastrointestinal and genitourinary toxicity of prostate cancer patients undergoing intensity-modulated versus conventional radiotherapy using localized fields

Data on the benefit of the use of IMRT are critically important if we are to understand the dosimetric and clinical tradeoffs of IMRT over conventional techniques and to design future technical and ...
ascopubs.org

Prospective validation of single nucleotide polymorphisms as predictors of gastrointestinal, genitourinary, and sexual toxicities following radiation therapy for prostate cancer.

Polo-like kinase-1 as a potential prognostic marker of prostate cancer utilizing ORIEN data. This is an ASCO Meeting Abstract from the 2023 ASCO Genitourinary Cancers Symposium. This abstract does not ...
Cure Today

Enrollment Opens for Trial Evaluating Abelacimab for Blood Clots From Gastrointestinal, Genitourinary Cancers

The phase 3 MAGNOLIA trial will assess whether abelacimab can prevent venous thromboembolism recurrence in patients with gastrointestinal or genitourinary cancers. Recruitment has started for a phase ...